Display Settings:

Format

Send to:

Choose Destination
    ChemMedChem. 2010 May 3;5(5):730-8.

    A highly potent and selective caspase 1 inhibitor that utilizes a key 3-cyanopropanoic acid moiety.

    Source

    National Institutes of Health, National Human Genome Research Institute, NIH Chemical Genomics Center, Rockville, Maryland 20850, USA.

    Abstract

    Herein, we examine the potential of a nitrile-containing propionic acid moiety as an electrophile for covalent attack by the active-site cysteine residue of caspase 1. The syntheses of several cyanopropanate-containing small molecules based on the optimized peptidic scaffold of prodrug VX-765 were accomplished. These compounds were found to be potent inhibitors of caspase 1 (IC(50) values < or =1 nM). Examination of these novel small molecules against a caspase panel demonstrated an impressive degree of selectivity for caspase 1 inhibition over other caspase isozymes. Assessment of hydrolytic stability and selected ADME properties highlighted these agents as potentially useful tools for studying caspase 1 down-regulation in various settings, including in vivo analyses.

    PMID:
    20229566
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC3062473
    Free PMC Article

    Images from this publication.See all images (7) Free text

    Figure 1
    Scheme 2
    Figure 2
    Figure 4
    Scheme 1
    Scheme 3
    Figure 3

      Supplemental Content

      Icon for John Wiley & Sons, Inc. Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk